Partner with us
Working Together to
transform Patients’ Lives
We collaborate with like-minded companies innovating with impactful science, focusing on bringing their breakthrough healthcare advancements to the world.
In recent years, there has been a shift in the landscape of New Molecular Entity (NME) approvals by global regulatory agencies. Increasingly a majority of these innovative assets, accelerating patient outcomes, originate from small and mid-size research companies. Provectis aspires to help these companies succeed in a complex landscape, advancing their breakthrough research and accelerating patient-centric outcomes.
ethical and compliance framework
Pre Launch
- Assessment of regulatory requirements in developed and emerging markets
- Regulatory filing and reimbursement
- Market access and pricing advisory for Europe, Asia and the Middle East
- Competitive readiness
- Building pre-launch medical advocacy
- Conducting access and reimbursement bridging clinical studies.
Launch
- Early medical and field force deployment
- AdBoards and launch meetings
- Integrated launch review
- Integrated Product Strategy at launch
- Representation at medical congresses
- Medical and field promotion
Post Launch
- Key account management for hospital listing
- Public affairs and building government advocacy for faster access
- Distribution channel management
- Patients' and physicians' feedback to principal companies
- ADR monitoring, documentation and reporting
- Performance excellence and business growth
Brand Maximization
- Market presence strengthening by revisiting promotion strategy, medical advocacy, field deployment and channel management
- Competition monitoring for patent infringement and alert principles
- Regular performance review planning with principals and updates on market realities
Portfolio Enhancement
- Assistance on product patent life extension by developing differentiated forms
- Development of new indications
- Strategic advisory on entering new markets and market segments
Headquartered in Basel, Switzerland, we are an agile and flexible commercial partner with
a partnership network in Europe, Asia, the Middle East, and Oceania.
The provectis
Advantage
We partner with biopharmaceutical companies conducting cutting-edge research, fostering long-term relationships, to deliver their trailblazing solutions to patients. Our partners collaborate with us for what we bring to the table and what we call ARC:
Approach
We are an agile, nimble, and flexible commercial healthcare company seeking innovative companies to collaborate with to deliver life-changing solutions for patients.People, data, and technology power us. Our complementary pharma expertise, ethical core values, and inclusive culture guide us.
Reach
We have a deep geographical reach and a strong partner network in the developing markets of Asia and the Middle East, and the developed market of Europe.Our leadership team brings several years of multi-country, multi-region MNC experience in the pharmaceutical industry. Our headquarters in Basel, Switzerland, affords us extensive knowledge of the area.
Capabilities
From launching innovation and building medical advocacy to undertaking ethical promotion and bringing patient feedback to pioneers, we drive growth for our partners.
Our team brings to the table expertise in global business development and licensing, market access and pricing, launch excellence, government advocacy, competitive readiness, resource planning and financial management, and more.
